Aldosterone impairs vascular reactivity by decreasing glucose-6-phosphate dehydrogenase activity (original) (raw)

• Blacher, J. et al. Association between increased plasma levels of aldosterone and decreased systemic arterial compliance in subjects with essential hypertension. Am. J. Hypertens. 10, 1326–1334 (1997).
  Article CAS Google Scholar
• Duprez, D.A. et al. Inverse relationship between aldosterone and large artery compliance in chronically treated heart failure patients. Eur. Heart J. 19, 1371–1376 (1998).
  Article CAS Google Scholar
• Weber, K.T. Aldosteronism revisited: perspectives on less well-recognized actions of aldosterone. J. Lab. Clin. Med. 142, 71–82 (2003).
  Article CAS Google Scholar
• Farquharson, C.A. & Struthers, A.D. Spironolactone increases nitric oxide bioactivity, improves endothelial vasodilator dysfunction, and suppresses vascular angiotensin I/angiotensin II conversion in patients with chronic heart failure. Circulation 101, 594–597 (2000).
  Article CAS Google Scholar
• Struthers, A.D. Aldosterone-induced vasculopathy. Mol. Cell. Endocrinol. 217, 239–241 (2004).
  Article CAS Google Scholar
• Leopold, J.A., Cap, A., Scribner, A.W., Stanton, R.C. & Loscalzo, J. Glucose-6-phosphate dehydrogenase deficiency promotes endothelial oxidant stress and decreases endothelial nitric oxide bioavailability. FASEB J. 15, 1771–1773 (2001).
  Article CAS Google Scholar
• Leopold, J.A., Zhang, Y.Y., Scribner, A.W., Stanton, R.C. & Loscalzo, J. Glucose-6-phosphate dehydrogenase overexpression decreases endothelial cell oxidant stress and increases bioavailable nitric oxide. Arterioscler. Thromb. Vasc. Biol. 23, 411–417 (2003).
  Article CAS Google Scholar
• Criss, W.E. & McKerns, K.W. Inhibitors of the catalytic activity of bovine adrenal glucose-6- phosphate dehydrogenase. Biochim. Biophys. Acta 184, 486–494 (1969).
  Article CAS Google Scholar
• Liew, C.C. & Gornall, A.G. Effects of aldosterone on blood pressure and glucose-6-phosphate dehydrogenase activity of heart muscle. Can. J. Physiol. Pharmacol. 47, 193–197 (1969).
  Article CAS Google Scholar
• Xu, Y., Osborne, B.W. & Stanton, R.C. Diabetes causes inhibition of glucose-6-phosphate dehydrogenase via activation of PKA, which contributes to oxidative stress in rat kidney cortex. Am. J. Physiol. Renal Physiol. 289, F1040–F1047 (2005).
  Article CAS Google Scholar
• Guo, L., Zhang, Z., Green, K. & Stanton, R.C. Suppression of interleukin-1 beta-induced nitric oxide production in RINm5F cells by inhibition of glucose-6-phosphate dehydrogenase. Biochemistry 41, 14726–14733 (2002).
  Article CAS Google Scholar
• Macho, B. & Sassone-Corsi, P. Functional analysis of transcription factors CREB and CREM. Methods Enzymol. 370, 396–415 (2003).
  Article CAS Google Scholar
• Zhang, X. et al. Genome-wide analysis of cAMP-response element binding protein occupancy, phosphorylation, and target gene activation in human tissues. Proc. Natl. Acad. Sci. USA 102, 4459–4464 (2005).
  Article CAS Google Scholar
• Manna, P.R. et al. Regulation of steroidogenesis and the steroidogenic acute regulatory protein by a member of the cAMP response-element binding protein family. Mol. Endocrinol. 16, 184–199 (2002).
  Article CAS Google Scholar
• Klatt, P. et al. Characterization of heme-deficient neuronal nitric-oxide synthase reveals a role for heme in subunit dimerization and binding of the amino acid substrate and tetrahydrobiopterin. J. Biol. Chem. 271, 7336–7342 (1996).
  Article CAS Google Scholar
• Cai, S., Khoo, J., Mussa, S., Alp, N.J. & Channon, K.M. Endothelial nitric oxide synthase dysfunction in diabetic mice: importance of tetrahydrobiopterin in eNOS dimerisation. Diabetologia 48, 1933–1940 (2005).
  Article CAS Google Scholar
• Leopold, J.A. et al. Glucose-6-phosphate dehydrogenase modulates vascular endothelial growth factor-mediated angiogenesis. J. Biol. Chem. 278, 32100–32106 (2003).
  Article CAS Google Scholar
• Ding, H. et al. Endothelial dysfunction in the streptozotocin-induced diabetic apoE-deficient mouse. Br. J. Pharmcol. 146, 1110–1118 (2005).
  Article CAS Google Scholar
• Rousseau, M.F. et al. Beneficial neurohormonal profile of spironolactone in severe congestive heart failure: results from the RALES neurohormonal substudy. J. Am. Coll. Cardiol. 40, 1596–1601 (2002).
  Article CAS Google Scholar
• Silvestre, J.S. et al. Myocardial production of aldosterone and corticosterone in the rat. Physiological regulation. J. Biol. Chem. 273, 4883–4891 (1998).
  Article CAS Google Scholar
• Weber, K.T. Aldosterone in congestive heart failure. N. Engl. J. Med. 345, 1689–1697 (2001).
  Article CAS Google Scholar
• Massaad, C., Houard, N., Lombes, M. & Barouki, R. Modulation of human mineralocorticoid receptor function by protein kinase A. Mol. Endocrinol. 13, 57–65 (1999).
  Article CAS Google Scholar
• Booth, R.E., Johnson, J.P. & Stockand, J.D. Aldosterone. Adv. Physiol. Educ. 26, 8–20 (2002).
  Article Google Scholar
• Mioduszewska, B., Jaworski, J. & Kaczmarek, L. Inducible cAMP early repressor (ICER) in the nervous system–a transcriptional regulator of neuronal plasticity and programmed cell death. J. Neurochem. 87, 1313–1320 (2003).
  Article CAS Google Scholar
• Boissel, J.P., Bros, M., Schrock, A., Godtel-Armbrust, U. & Forstermann, U. Cyclic AMP-mediated upregulation of the expression of neuronal NO synthase in human A673 neuroepithelioma cells results in a decrease in the level of bioactive NO production: analysis of the signaling mechanisms that are involved. Biochemistry 43, 7197–7206 (2004).
  Article CAS Google Scholar
• Shepard, J.D., Liu, Y., Sassone-Corsi, P. & Aguilera, G. Role of glucocorticoids and cAMP-mediated repression in limiting corticotropin-releasing hormone transcription during stress. J. Neurosci. 25, 4073–4081 (2005).
  Article CAS Google Scholar
• Ding, B. et al. A positive feedback loop of phosphodiesterase 3 (PDE3) and inducible cAMP early repressor (ICER) leads to cardiomyocyte apoptosis. Proc. Natl. Acad. Sci. USA 102, 14771–14776 (2005).
  Article CAS Google Scholar
• Nagata, D. et al. Molecular mechanism of the inhibitory effect of aldosterone on endothelial NO synthase activity. Hypertension 48, 165–171 (2006).
  Article CAS Google Scholar
• Sun, Y. et al. Aldosterone-induced inflammation in the rat heart: role of oxidative stress. Am. J. Pathol. 161, 1773–1781 (2002).
  Article CAS Google Scholar
• Schafer, A. et al. Addition of the selective aldosterone receptor antagonist eplerenone to ACE inhibition in heart failure: effect on endothelial dysfunction. Cardiovasc. Res. 58, 655–662 (2003).
  Article CAS Google Scholar
• Matsui, R. et al. Glucose-6 phosphate dehydrogenase deficiency decreases the vascular response to angiotensin II. Circulation 112, 257–263 (2005).
  Article CAS Google Scholar
• Nishizaka, M.K., Zaman, M.A., Green, S.A., Renfroe, K.Y. & Calhoun, D.A. Impaired endothelium-dependent flow-mediated vasodilation in hypertensive subjects with hyperaldosteronism. Circulation 109, 2857–2861 (2004).
  Article CAS Google Scholar
• Abiose, A.K. et al. Effect of spironolactone on endothelial function in patients with congestive heart failure on conventional medical therapy. Am. J. Card. 93, 1564–1566 (2004).
  Article CAS Google Scholar
• Macdonald, J.E., Kennedy, N. & Struthers, A.D. Effects of spironolactone on endothelial function, vascular angiotensin converting enzyme activity, and other prognostic markers in patients with mild heart failure already taking optimal treatment. Heart 90, 765–770 (2004).
  Article CAS Google Scholar
• Davies, J.I., Band, M., Morris, A. & Struthers, A.D. Spironolactone impairs endothelial function and heart rate variability in patients with type 2 diabetes. Diabetologia 47, 1687–1694 (2004).
  Article CAS Google Scholar
• Zhang, Z., Apse, K., Pang, J. & Stanton, R.C. High glucose inhibits glucose-6-phosphate dehydrogenase via cAMP in aortic endothelial cells. J. Biol. Chem. 275, 40042–40047 (2000).
  Article CAS Google Scholar
• Garnier, A. et al. Cardiac specific increase in aldosterone production induces coronary dysfunction in aldosterone synthase-transgenic mice. Circulation 110, 1819–1825 (2004).
  Article CAS Google Scholar
• Forgione, M.A. et al. The A326G (A+) variant of the glucose-6-phosphate dehydrogenase gene is associated with endothelial dysfunction in African Americans. J. Am. Coll. Cardiol. 41, 249A (2003).
  Article Google Scholar
• Leopold, J.A. & Loscalzo, J. Cyclic strain modulates resistance to oxidant stress by increasing G6PDH expression in smooth muscle cells. Am. J. Physiol. Heart Circ. Physiol. 279, H2477–H2485 (2000).
  Article CAS Google Scholar
• Zhang, Y.Y. et al. Expression of 5-lipoxygenase in pulmonary artery endothelial cells. Biochem. J. 361, 267–276 (2002).
  Article CAS Google Scholar
• Dong, Q.G. et al. A general strategy for isolation of endothelial cells from murine tissues. Characterization of two endothelial cell lines from the murine lung and subcutaneous sponge implants. Arterioscler. Thromb. Vasc. Biol. 17, 1599–1604 (1997).
  Article CAS Google Scholar
• Zhang, Z., Yu, J. & Stanton, R.C. A method for determination of pyridine nucleotides using a single extract. Anal. Biochem. 285, 163–167 (2000).
  Article CAS Google Scholar
• Zhang, M.X. et al. Regulation of endothelial nitric oxide synthase by small RNA. Proc. Natl. Acad. Sci. USA 102, 16967–16972 (2005).
  Article CAS Google Scholar
• Uittenbogaard, A., Shaul, P.W., Yuhanna, I.S., Blair, A. & Smart, E.J. High density lipoprotein prevents oxidized low density lipoprotein-induced inhibition of endothelial nitric-oxide synthase localization and activation in caveolae. J. Biol. Chem. 275, 11278–11283 (2000).
  Article CAS Google Scholar
• Hou, J., Speirs, H.J., Seckl, J.R. & Brown, R.W. Sgk1 gene expression in kidney and its regulation by aldosterone: spatio-temporal heterogeneity and quantitative analysis. J. Am. Soc. Nephrol. 13, 1190–1198 (2002).
  Article CAS Google Scholar
• Michel, F. et al. Aldosterone enhances ischemia-induced neovascularization through angiotensin II-dependent pathway. Circulation 109, 1933–1937 (2004).
  Article CAS Google Scholar
• Eberhardt, R.T. et al. Endothelial dysfunction in a murine model of mild hyperhomocyst(e)inemia. J. Clin. Invest. 106, 483–491 (2000).
  Article CAS Google Scholar
• Virdis, A. et al. Effect of hyperhomocystinemia and hypertension on endothelial function in methylenetetrahydrofolate reductase-deficient mice. Arterioscler. Thromb. Vasc. Biol. 23, 1352–1357 (2003).
  Article CAS Google Scholar